Ultragenyx Pharmaceutical (RARE) FCF Margin (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9,746.00 |
| Dec 31, 2025 | 983.00 |
| Sep 30, 2025 | 903.00 |
| Jun 30, 2025 | 5,316.00 |
| Mar 31, 2025 | -7,187.00 |
| Dec 31, 2024 | 401.00 |
| Sep 30, 2024 | -20.00 |
| Jun 30, 2024 | 12,434.00 |
| Mar 31, 2024 | -13,597.00 |
| Dec 31, 2023 | 11,710.00 |
| Sep 30, 2023 | -5,314.00 |
| Jun 30, 2023 | 6,077.00 |
| Mar 31, 2023 | -8,016.00 |
| Dec 31, 2022 | 1,725.00 |
| Sep 30, 2022 | -1,777.00 |
| Jun 30, 2022 | 9,352.00 |
| Mar 31, 2022 | -9,361.00 |
| Dec 31, 2021 | 1,382.00 |
| Sep 30, 2021 | -2.00 |
| Jun 30, 2021 | 7,861.00 |
| Mar 31, 2021 | -8,463.00 |
| Dec 31, 2020 | -1,150.00 |
| Sep 30, 2020 | -21,564.00 |
| Jun 30, 2020 | 43,582.00 |
| Mar 31, 2020 | -6,618.00 |
| Dec 31, 2019 | 12,785.00 |
| Sep 30, 2019 | 2,795.00 |
| Jun 30, 2019 | 15,338.00 |
| Mar 31, 2019 | -19,307.00 |
| Dec 31, 2018 | 24,588.00 |
| Sep 30, 2018 | 871.00 |
| Jun 30, 2018 | 23,709.00 |
| Mar 31, 2018 | 298,270.00 |
| Dec 31, 2017 | 2.80 Mn |
| Dec 31, 2016 | -73.75 Mn |
| Sep 30, 2016 | 23.43 Mn |